Literature DB >> 6337748

Serum bile acid analysis.

K D Setchell, A Matsui.   

Abstract

Routine and research techniques are outlined for the analysis of bile acids in serum. The basis of these techniques is the use of liquid-solid extraction and liquid-gel chromatography coupled with the measurement of bile acids by gas chromatography using high resolution glass capillary columns and mass spectrometry which provides increased sensitivity compared with conventional methods of measurement. Problems associated with the isolation and purification of bile acids from serum are discussed and rapid and flexible methods for their metabolic profiling are described. The advantages and applicability of these procedures are illustrated with examples of profiles of bile acids in the serum from normal subjects, patients with liver disease and a patient with an ileal resection.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6337748     DOI: 10.1016/0009-8981(83)90070-0

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  26 in total

1.  Separate transport systems for biliary secretion of sulfated and unsulfated bile acids in the rat.

Authors:  F Kuipers; M Enserink; R Havinga; A B van der Steen; M J Hardonk; J Fevery; R J Vonk
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

Review 2.  Isolation and determination of bile acids.

Authors:  J Kandrac; S Kevresan; J K Gu; M Mikov; J P Fawcett; K Kuhajda
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2006 Jul-Sep       Impact factor: 2.441

3.  Specific bile acids inhibit hepatic fatty acid uptake in mice.

Authors:  Biao Nie; Hyo Min Park; Melissa Kazantzis; Min Lin; Amy Henkin; Stephanie Ng; Sujin Song; Yuli Chen; Heather Tran; Robin Lai; Chris Her; Jacquelyn J Maher; Barry M Forman; Andreas Stahl
Journal:  Hepatology       Date:  2012-10       Impact factor: 17.425

4.  The membrane protein ATPase class I type 8B member 1 signals through protein kinase C zeta to activate the farnesoid X receptor.

Authors:  Tamara Frankenberg; Tamir Miloh; Frank Y Chen; Meena Ananthanarayanan; An-Qiang Sun; Natarajan Balasubramaniyan; Irwin Arias; Kenneth D R Setchell; Frederick J Suchy; Benjamin L Shneider
Journal:  Hepatology       Date:  2008-12       Impact factor: 17.425

5.  Biotinylated single-chain variable fragment-based enzyme-linked immunosorbent assay for glycocholic acid.

Authors:  Xiping Cui; Natalia Vasylieva; Ding Shen; Bogdan Barnych; Jun Yang; Qiyi He; Zhengyun Jiang; Suqing Zhao; Bruce D Hammock
Journal:  Analyst       Date:  2018-04-30       Impact factor: 4.616

6.  Bile acid profiles in peroxisomal 3-oxoacyl-coenzyme A thiolase deficiency.

Authors:  P T Clayton; E Patel; A M Lawson; R A Carruthers; J Collins
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

7.  Prolonged large bowel transit increases serum deoxycholic acid: a risk factor for octreotide induced gallstones.

Authors:  M J Veysey; L A Thomas; A I Mallet; P J Jenkins; G M Besser; J A Wass; G M Murphy; R H Dowling
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

8.  Delta 4-3-oxosteroid 5 beta-reductase deficiency described in identical twins with neonatal hepatitis. A new inborn error in bile acid synthesis.

Authors:  K D Setchell; F J Suchy; M B Welsh; L Zimmer-Nechemias; J Heubi; W F Balistreri
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

9.  Farnesoid X receptor (FXR) gene deficiency impairs urine concentration in mice.

Authors:  Xiaoyan Zhang; Shizheng Huang; Min Gao; Jia Liu; Xiao Jia; Qifei Han; Senfeng Zheng; Yifei Miao; Shuo Li; Haoyu Weng; Xuan Xia; Shengnan Du; Wanfu Wu; Jan-Åke Gustafsson; Youfei Guan
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-24       Impact factor: 11.205

10.  Familial giant cell hepatitis associated with synthesis of 3 beta, 7 alpha-dihydroxy-and 3 beta,7 alpha, 12 alpha-trihydroxy-5-cholenoic acids.

Authors:  P T Clayton; J V Leonard; A M Lawson; K D Setchell; S Andersson; B Egestad; J Sjövall
Journal:  J Clin Invest       Date:  1987-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.